Near Karen A, Stowers Anthony W, Jankovic Dragana, Kaslow David C
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-0425, USA.
Infect Immun. 2002 Feb;70(2):692-701. doi: 10.1128/IAI.70.2.692-701.2002.
Vaccination of mice with yeast-secreted Plasmodium yoelii-derived 19-kilodalton merozoite surface protein 1 (yMSP1(19)) has been shown to afford protection from challenge with a lethal strain of P. yoelii. Sterile immunity can be achieved when MSP1(19) is emulsified in Freund adjuvant but not when it is adsorbed to aluminum hydroxide gel (alum). Because complete Freund adjuvant is not an acceptable adjuvant for use in humans, alternative adjuvants must be identified for formulating MSP1(19) as a vaccine for use in humans. To determine whether oligodeoxynucleotides with CpG motifs (ODN), reported to be a powerful new class of adjuvants, could enhance the immunogenicity of yMSP1(19), C57BL/6 mice were vaccinated either with yMSP1(19) formulated with Freund adjuvant, with alum, or with ODN plus alum and challenged intravenously with P. yoelii 17XL asexual blood-stage parasites. Adsorption of immunogen and adjuvant to alum was optimized by adjusting buffer (phosphate versus acetate) and pH. We found that the adjuvant combination of ODN plus alum with yMSP1(19), injected intraperitoneally (i.p.), increased immunoglobulin G (IgG) yMSP1(19)-specific antibody production 12-fold over Freund adjuvant given i.p., 3-fold over Freund adjuvant given subcutaneously (s.c.), 300-fold over alum given i.p., and 48-fold over alum given s.c. The predominant antibody isotype in the group receiving alum-ODN-yMSP1(19) was IgG1. Increased antibody levels correlated to protection from a challenge with P. yoelii 17XL. Supernatant cytokine levels of gamma interferon in yMSP1(19)-stimulated splenocytes were dramatically elevated in the alum-ODN-yMSP1(19) group. Interleukin-10 (IL-10) levels were also elevated; however, no IL-5 was detected. The cytokine profile, as well as the predominant IgG1 antibody isotype, suggests the protective immune response was a mixed Th1/Th2 response.
用酵母分泌的约氏疟原虫来源的19千道尔顿裂殖子表面蛋白1(yMSP1(19))对小鼠进行疫苗接种已显示可使其免受致死性约氏疟原虫株的攻击。当MSP1(19)乳化于弗氏佐剂中时可实现无菌免疫,但吸附于氢氧化铝凝胶(明矾)时则不能。由于完全弗氏佐剂不可用于人体,因此必须确定替代佐剂,以便将MSP1(19)配制成用于人体的疫苗。为了确定据报道是一类强大新型佐剂的含CpG基序的寡脱氧核苷酸(ODN)是否能增强yMSP1(19)的免疫原性,用弗氏佐剂配制的yMSP1(19)、明矾或ODN加明矾对C57BL/6小鼠进行疫苗接种,并静脉注射约氏疟原虫17XL无性血液期寄生虫进行攻击。通过调整缓冲液(磷酸盐与乙酸盐)和pH值优化免疫原和佐剂对明矾的吸附。我们发现,腹腔注射(i.p.)ODN加明矾与yMSP1(19)的佐剂组合,使免疫球蛋白G(IgG)yMSP1(19)特异性抗体产生量比腹腔注射弗氏佐剂增加12倍,比皮下注射(s.c.)弗氏佐剂增加3倍,比腹腔注射明矾增加300倍,比皮下注射明矾增加48倍。接受明矾-ODN-yMSP1(19)的组中主要抗体亚型为IgG1。抗体水平升高与免受约氏疟原虫17XL攻击的保护作用相关。在明矾-ODN-yMSP1(19)组中,yMSP1(19)刺激的脾细胞中γ干扰素的上清细胞因子水平显著升高。白细胞介素-10(IL-10)水平也升高;然而,未检测到IL-5。细胞因子谱以及主要的IgG1抗体亚型表明保护性免疫反应为混合Th1/Th2反应。